跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,320 条关于
“IL-13Rα1/IL-4Rα”
全部
3,320
临床试验
1,307
药物
685
机构
18
资讯
1,310
2年前
FDA Approves Lilly's Ebglyss (lebrikizumab) for Moderate-to-Severe Atopic Dermatitis
8个月前
Almirall Launches Phase III Trial Testing Lebrikizumab for Nummular Eczema Treatment
去年
First-in-Class IL-4Rα/ST2 Bispecific Antibody AK139 Advances to Clinical Development for Inflammatory Diseases
去年
Mabgeek's MG-K10 Advances to Phase III Trials with Chime Biologics' Support
12个月前
Landmark Clinical Trials Demonstrate Efficacy of IL-13 and IL-4/IL-13 Inhibitors in Patients with Darker Skin Tones
去年
Medicenna Secures Five New Patents for IL-2 and IL-4 Superkine Immunotherapies
2年前
Medicenna Presents Preclinical Data on IL-2 Super-Antagonist MDNA209 and Anti-PD1-IL-2 BiSKIT MDNA113
去年
IL-17 and IL-23 Inhibitors Show Promising Safety and Efficacy Profiles in Elderly Psoriasis Patients
8个月前
Turn Therapeutics Advances Phase 2 Atopic Dermatitis Trial with First-in-Class IL-36/IL-31 Inhibitor GX-03
10个月前
Mabwell's Anti-IL-11 Antibody 9MW3811 Becomes World's First IL-11 Therapeutic to Enter Phase II for Pathological Scarring
第 1 页,共 131 页
上一页
下一页